Condition
Squamous Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Squamous Cell Lung Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (2), Italy (1), United States (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Squamous Cell Lung Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| C-CAR031 CAR T-cell infusion for GPC3-positive advanced squamous cell lung cancer | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Mar 2, 2026 |
| Testing ZEN003694 for advanced squamous cell lung cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Nov 7, 2022 |
| Building a national network for lung cancer treatment in Italy | — | Milan | Recruiting | Sep 22, 2022 |
| Immunotherapy using GPC3-targeted CAR-T cells for liver cancer | Phase 1 | Guangzhou, Guangdong and 1 other locations | Recruiting | Jun 26, 2017 |
All recruiting trials (4)
-
C-CAR031 CAR T-cell infusion for GPC3-positive advanced squamous cell lung cancer
This trial will test a CAR T-cell infusion called C-CAR031 in adults with GPC3-positive advanced or metastatic squamous cell lung cancer who have progressed on or cannot tolerate up to three prior systemic treatments.
-
Testing ZEN003694 for advanced squamous cell lung cancer
This study is testing a new drug called ZEN003694 to see if it can help people with advanced squamous cell lung cancer that has a specific gene mutation.
-
Building a national network for lung cancer treatment in Italy
This study is trying to create a nationwide network in Italy to gather information and improve treatments for advanced lung cancer patients using new therapies like immunotherapy.
-
Immunotherapy using GPC3-targeted CAR-T cells for liver cancer
This study is testing a new treatment using specially modified immune cells to see if they can help people with advanced liver cancer that has a specific protein called GPC3.
Related topics
Quick answers
How many Squamous Cell Lung Cancer clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.